| Pharmaceutical active ingredients: |
| Benserazide HydrochlorideLevodopa |
| Available forms, composition and doses of Madopar LT: |
| Tablets; Oral; Levodopa; Benserazide Hydrochloride |
| Madopar LT medical category: |
| Human:Antiparkinsonian drugsMiscellaneous central nervous system agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N04BA02 - Levodopa and decarboxylase inhibitor |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Roche |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Madopar DR | Benserazide Hydrochloride; Levodopa | Roche |
| Madopar Dual Release | Benserazide Hydrochloride; Levodopa | Roche |
| Madopar GSS | Benserazide Hydrochloride; Levodopa | Roche |
| Madopar HBS | Benserazide Hydrochloride; Levodopa | Roche; DKSH; Firma Chun Cheong; Zentiva; Zuellig Pharma |
| Madopar LIQ | Benserazide Hydrochloride; Levodopa | Roche |
| Madopar T | Benserazide Hydrochloride; Levodopa | Roche |
| Madopark | Benserazide Hydrochloride; Levodopa | Roche |
| Modopar | Benserazide Hydrochloride; Levodopa | Roche |
| Modopar Dispersible | Benserazide Hydrochloride; Levodopa | Roche |
| Modopar LP | Benserazide Hydrochloride; Levodopa | Roche |